GI & Endoscopy

Japan's Takeda Pharmaceuticals and San Diego's PvP Biologics are developing KumaMax, a novel enzyme that breaks down immune-reactive parts of gluten in the stomach, for patients with Celiac disease.

The American Academy of Pediatrics awarded the 2016 Murray Davidson Award to Steven M. Schwarz, MD.

Blue Cross Blue Shield Association's Center for Clinical Effectiveness positively reviewed Madison, Wis.-based Exact Sciences' Cologuard, a fecal-based colonoscopy alternative.

Here are three gastroenterologists in the news this past week.

J. Calvin Coffey, PhD, of Ireland-based University of Limerick, argues that a structure in the digestive system should be classified as a new organ.

Joseph Binns, MD, is a gastroenterologist at Red Bank (N.J.) Gastroenterology.

The pancreatitis program at Methodist Dallas Medical Center earned a Gold Seal of Approval from The Joint Commission, Dallas/Fort Worth Healthcare Daily reports.

Lancaster Gastroenterology and RGAL Gastroenterology Specialists merged practices, becoming Regional GI, Lancaster Online reports.

Laval, Canada-based Valeant Pharmaceuticals' board of directors elected Richard DeSchutter director.

Researchers from Nashville, Tenn.-based Vanderbilt University created an endoscope that uses Raman spectroscopy, a chemical-fingerprinting technique, to detect inflammatory bowel disease in the colon.